WHO ICTRP trial
Additional Impact of Very High Power Short-Duration Ablation on Esophageal…
ChiCTR2500098582 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500098582 |
|---|---|
| Public title | Additional Impact of Very High Power Short-Duration Ablation on Esophageal Injury After Catheter Ablation of Persistent Atrial Fibrillation: A Single-Center, Prospective, Single-Arm Clinical Study |
| Scientific title | Additional Impact of Very High Power Short-Duration Ablation on Esophageal Injury After Catheter Ablation of Persistent Atrial Fibrillation: A Single-Center, Prospective, Single-Arm Clinical Study |
| Primary sponsor | Yan'an Hospital, Kunming |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | persistent atrial fibrillation |
| Interventions | experimental group:The "QMODE+" ablation mode is used to perform a "modified BOX lesion technique" |
| Registration date | Mar 11, 2025 |
| Target size | experimental group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: